Testing effectiveness (Phase 2)UnknownNCT02294565
What this trial is testing
VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer
Who this might be right for
Breast Cancer
Vestan, Inc. 147
Showing 20 of 150 results